MENLO PARK, Calif., Feb. 1, 2024 /PRNewswire/ -- Cortex announced today the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in late October 2023. The international, ...
MENLO PARK, Calif., Feb. 3, 2023 /PRNewswire/ -- Ablacon, Inc., an Ajax Health and Zeus Health-backed developer of an innovative mapping system to guide the treatment of atrial fibrillation (AF), ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果